| Jangka wektu | Prediksi rega | kepungkur | Sajarah | Wawasan |
|---|---|---|---|---|
| sesuk | $9.88 ▲ +1.24% | wingi | $9.71 ▼ -0.52% | Sesuk 4D Molecular Therapeutics Inc. Common Stock (FDMT) persiyapan wis anchored kanggo $9.76 lan target $9.88 (+1.24%). Waca sing cedhak yaiku munggah; nonton $10.05 / $9.47 amarga volatilitas sing diwujudake saben dina babagan 6.38%. |
Sesuk 4D Molecular Therapeutics Inc. Common Stock (FDMT) persiyapan wis anchored kanggo $9.76 lan target $9.88 (+1.24%). Waca sing cedhak yaiku munggah; nonton $10.05 / $9.47 amarga volatilitas sing diwujudake saben dina babagan 6.38%. | ||||
| Minggu | $10.14 ▲ +3.85% | Minggu kepungkur | $9.60 ▼ -1.62% | Model 7 dina 4D Molecular Therapeutics Inc. Common Stock pindhah saka $9.60 menyang $10.14 (+3.85%). Iku menehi konteks momentum munggah kanggo saham iki, supaya break watara $10.05 / $9.47 prakara luwih saka siji obah. |
Model 7 dina 4D Molecular Therapeutics Inc. Common Stock pindhah saka $9.60 menyang $10.14 (+3.85%). Iku menehi konteks momentum munggah kanggo saham iki, supaya break watara $10.05 / $9.47 prakara luwih saka siji obah. | ||||
| wulan | $10.56 ▲ +8.20% | Wulan kepungkur | $9.42 ▼ -3.44% | Target 1 wulan 4D Molecular Therapeutics Inc. Common Stock yaiku $10.56 (+8.20%), dibandhingake karo referensi langsung ing cedhak $9.76. Cakrawala iki nyampur tekanan tren saiki karo momentum rega, likuiditas, lan risiko khusus perusahaan. |
Target 1 wulan 4D Molecular Therapeutics Inc. Common Stock yaiku $10.56 (+8.20%), dibandhingake karo referensi langsung ing cedhak $9.76. Cakrawala iki nyampur tekanan tren saiki karo momentum rega, likuiditas, lan risiko khusus perusahaan. | ||||
| taun | $11.20 ▲ +14.72% | Taun kepungkur | $9.16 ▼ -6.18% | Skenario 1 taun 4D Molecular Therapeutics Inc. Common Stock nuduhake $11.20 (+14.72%). Kapercayan luwih murah tinimbang baris jangka pendek, mula dianggep minangka konteks siklus lan priksa maneh sawise nganyari data pasar utama. |
Skenario 1 taun 4D Molecular Therapeutics Inc. Common Stock nuduhake $11.20 (+14.72%). Kapercayan luwih murah tinimbang baris jangka pendek, mula dianggep minangka konteks siklus lan priksa maneh sawise nganyari data pasar utama. | ||||
| 5 Taun | $12.69 ▲ +30.00% | 5 Taun kepungkur | $8.53 ▼ -12.60% | Tampilan 5 taun 4D Molecular Therapeutics Inc. Common Stock yaiku $12.69 (+30.00%). Iki minangka skenario arah sing dibangun saka owahing arah lan volatilitas sing diwatesi, dudu dalan sing dijamin. |
Tampilan 5 taun 4D Molecular Therapeutics Inc. Common Stock yaiku $12.69 (+30.00%). Iki minangka skenario arah sing dibangun saka owahing arah lan volatilitas sing diwatesi, dudu dalan sing dijamin. | ||||
| Indikator | Nilai | Sinyal |
|---|---|---|
| regane | $9.76 | agêng |
| Ganti saben dina | -3.08% | Ngisor |
| Volatilitas Kab | 20.0% | agêng |
| kapercayan | 64% | Ndhuwur |
| Sumber Data | nasdaq-screener | agêng |
| saiki | $9.76 | Ganti saben dina | -3.08% |
| Pasar Kab | $498.26M | Sumber | nasdaq-screener |
Gagasan sing gegandhengan kanggo navigasi internal, diklompokaké miturut persiyapan sisih ndhuwur sing luwih kuwat lan kurang lemah ing pasar sing padha.